Author Topic: 685 Tysabri-related PML cases as of 9/7/16  (Read 35 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 7379
  • Location: Pacific Northwest
685 Tysabri-related PML cases as of 9/7/16
« on: December 12, 2016, 03:31:46 pm »
As of September 7, 2016, there have been 685  confirmed Tysabri-related PML cases worldwide.  All but 3 of them have been people with MS. The other 3 are people with Crohn's disease.

As of August 31, 2016,  the overall PML incidence was 4.22 per 1000 patients (95% CI 3.91 to 4.55 per 1000 patients). 23% of the  patients have died. 77% of the patients are alive "with varying levels of disability."

As of June 30, 2016, roughly 156,500 patients received natalizumab (Tysabri) in  a post-marketing setting worldwide.

This information is from http://chefarztfrau.de/?page_id=716.






SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
41 Views
Last post April 13, 2016, 02:06:25 pm
by agate
0 Replies
27 Views
Last post July 14, 2016, 08:51:48 am
by agate
0 Replies
29 Views
Last post December 22, 2016, 06:00:29 pm
by agate
0 Replies
12 Views
Last post February 24, 2017, 11:15:22 am
by agate
3 Replies
27 Views
Last post June 26, 2017, 12:14:18 pm
by agate